Abstract
In patients with heart failure, excessive sympathetic activation during exercise could interfere with exercise performance by impairing arteriolar dilation in working muscle and by adversely altering skeletal muscle metabolic behavior. To test this hypothesis, we examined the effect of sympathoinhibition with clonidine, a central sympatholytic agent, on skeletal muscle blood flow and metabolism in patients with heart failure.
Original language | English |
---|---|
Pages (from-to) | 238-45 |
Number of pages | 8 |
Journal | Circulation |
Volume | 96 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1997 |